Ledger.Open graph →
SEC Form D · filed February 12, 2021

Blue Note Therapeutics, Inc

Offering
$30.0M
Sold
$13.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

John Harris · SAN FRANCISCO, CADirectorGeoffrey Eich · SAN FRANCISCO, CAExec · DirectorAndrew Firlik · SAN FRANCISCO, CADirectorYoun-Long Lin · Hsinchu County, F5DirectorThomas Spencer · Mendota Heights, MNExec · DirectorMatthew H. Wosk · Newton, MADirectorLaurence Bastien · San Antonio, TXExec · DirectorMichael J. Boyd · San Antonio, TXDirectorJason Hans · San Antonio, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗